Literature DB >> 29222319

HITs and misses in 100 years of heparin.

Lawrence Rice1.   

Abstract

Heparin was discovered 100 years ago, and the heparin-induced thrombocytopenia syndrome was described 40 years ago. That the most powerful anticoagulant of the last century can also produce the most extreme prothrombotic diathesis is but one of the paradoxes that surround heparin-induced thrombocytopenia. Standard treatment is alternative anticoagulation. Advances continue to be made regarding pathophysiology, prevention, and treatment. Currently, an epidemic of overdiagnosis threatens the well-being of patients, so efforts to educate clinicians on when and how to make this diagnosis are pressing.
© 2016 by The American Society of Hematology. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29222319      PMCID: PMC6142618          DOI: 10.1182/asheducation-2017.1.667

Source DB:  PubMed          Journal:  Hematology Am Soc Hematol Educ Program        ISSN: 1520-4383


  42 in total

1.  Arterial embolism occurring during systemic heparin therapy.

Authors:  R E WEISMANN; R W TOBIN
Journal:  AMA Arch Surg       Date:  1958-02

2.  Platelet factor 4 complexed to heparin is the target for antibodies generated in heparin-induced thrombocytopenia.

Authors:  J Amiral; F Bridey; M Dreyfus; A M Vissoc; E Fressinaud; M Wolf; D Meyer
Journal:  Thromb Haemost       Date:  1992-07-06       Impact factor: 5.249

Review 3.  Risk factors for heparin-induced thrombocytopenia: Focus on Fcγ receptors.

Authors:  Jérôme Rollin; Claire Pouplard; Yves Gruel
Journal:  Thromb Haemost       Date:  2016-06-30       Impact factor: 5.249

4.  A modified PF4-dependent, CD62p expression assay selectively detects serotonin-releasing antibodies in patients suspected of HIT.

Authors:  Anand Padmanabhan; Curtis G Jones; Daniel W Bougie; Brian R Curtis; Janice G McFarland; Demin Wang; Richard H Aster
Journal:  Thromb Haemost       Date:  2015-07-16       Impact factor: 5.249

5.  IVIg for Treatment of Severe Refractory Heparin-Induced Thrombocytopenia.

Authors:  Anand Padmanabhan; Curtis G Jones; Shannon M Pechauer; Brian R Curtis; Daniel W Bougie; Mehraboon S Irani; Barbara J Bryant; Jack B Alperin; Thomas G Deloughery; Kevin P Mulvey; Binod Dhakal; Renren Wen; Demin Wang; Richard H Aster
Journal:  Chest       Date:  2017-04-17       Impact factor: 9.410

6.  Heparin-induced thrombocytopenia. An unexpected response to treatment of consumption coagulopathy.

Authors:  E A Natelson; E C Lynch; C P Alfrey; J B Gross
Journal:  Ann Intern Med       Date:  1969-12       Impact factor: 25.391

Review 7.  Inferior vena cava filters.

Authors:  L Duffett; M Carrier
Journal:  J Thromb Haemost       Date:  2016-12-26       Impact factor: 5.824

Review 8.  The platelet serotonin-release assay.

Authors:  Theodore E Warkentin; Donald M Arnold; Ishac Nazi; John G Kelton
Journal:  Am J Hematol       Date:  2015-05-03       Impact factor: 10.047

Review 9.  Direct oral anticoagulants for treatment of HIT: update of Hamilton experience and literature review.

Authors:  Theodore E Warkentin; Menaka Pai; Lori-Ann Linkins
Journal:  Blood       Date:  2017-06-23       Impact factor: 22.113

Review 10.  Anticoagulant failure in coagulopathic patients: PTT confounding and other pitfalls.

Authors:  Theodore E Warkentin
Journal:  Expert Opin Drug Saf       Date:  2013-08-23       Impact factor: 4.250

View more
  4 in total

1.  Four Limb Ischemia: A Severe Case of Heparin Induced Thrombocytopenia.

Authors:  Kartik Anand; Ibrahim Ibrahim
Journal:  Indian J Hematol Blood Transfus       Date:  2019-01-31       Impact factor: 0.900

Review 2.  Assessing thrombocytopenia in the intensive care unit: the past, present, and future.

Authors:  Ryan Zarychanski; Donald S Houston
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

3.  Improving compliance with appropriateness of testing for heparin-induced thrombocytopaenia: a quality improvement report.

Authors:  Meric Mericliler; Vera Kazakova; Diala Nicolas; Utkarsh H Acharya; Bertrand L Jaber
Journal:  BMJ Open Qual       Date:  2022-07

4.  A prospective, blinded study of a PF4-dependent assay for HIT diagnosis.

Authors:  Bethany Samuelson Bannow; Deepti M Warad; Curtis G Jones; Shannon M Pechauer; Brian R Curtis; Daniel W Bougie; Ruchika Sharma; Diane E Grill; Mary W Redman; Parisa R Khalighi; Rachel R Leger; Rajiv K Pruthi; Dong Chen; Daniel E Sabath; Richard H Aster; David A Garcia; Anand Padmanabhan
Journal:  Blood       Date:  2021-02-25       Impact factor: 25.476

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.